Genetic deficiency in Pparg does not alter development of experimental prostate cancer

Nature Medicine

Volumn 9, Issue 10, 2003, Pages 1265-1266

  Saez, Enrique ^a,c   Olson, Peter ^a,b   Evans, Ronald M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ARTICLE; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLON TUMOR; DIABETES MELLITUS; DRUG RECEPTOR BINDING; FAT INTAKE; GENE ACTIVATION; GENE DELETION; GENE DOSAGE; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC DISORDER; HEMIZYGOTE; HUMAN; MULTIGENE FAMILY; MUTATIONAL ANALYSIS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROSTATE TUMOR; TRANSGENIC MOUSE;

ANIMALS; DISEASE MODELS, ANIMAL; HUMANS; MALE; MICE; NEOPLASMS, EXPERIMENTAL; PROSTATIC NEOPLASMS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TRANSCRIPTION FACTORS; TRANSGENES;

ANIMALIA; MUS MUSCULUS;

EID: 0142105505     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm928     Document Type: Article

References (8)

1. Lefebvre, A.M. et al. Nat. Med. 4, 1053-1057 (1998).
2. Saez, E. et al. Nat. Med. 4, 1058-1061 (1998).
3. Sarraf, P. et al. Nat. Med. 4, 1046-1052 (1998).
4. Sarraf, P. et al. Mol. Cell 3, 799-804 (1999).
5. Mueller, E. et al, Proc. Natl. Acad. Sci. USA 97, 10990-10995 (2000).
6. Huss, W.J., Maddison, L.A. & Greenberg, N.M. Semin. Cancer Biol. 11, 245-260 (2001).
7. Collett, G.P. et al. Clin. Cancer Res. 6, 3241-3248 (2000).
8. Paltoo, D. et al. Cancer Lett. 191, 67-74 (2003).